RT Journal Article
SR Electronic
A1 Helwick, Caroline
T1 Succinobucol Treatment Leads to Mixed Signals
JF MD Conference Express
YR 2007
FD SAGE Publications
VO 7
IS 1
SP 22
OP 23
DO 10.1177/155989770700700112
UL http://mdc.sagepub.com/content/7/1/22.abstract
AB Succinobucol (AGI-1067) is a novel compound believed to reduce inflammation in blood vessel walls. This article gives an overview of the findings from the Phase 3 randomized, double-blind Aggressive Reduction of Inflammation Stops Events [ARISE] study.